Small Pharma

Developer of psychedelic-based therapeutics for mental health conditions

placeLondon, England, United Kingdom calendar_todayFounded 2015 groups8 employees language smallpharma.com

Registered entities

Innovation

25 patent families (14 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,169 times.

YearFilings
20171
20181
20195
20203
20217
202218
202312
20243
20251

Investor mix

61 investors on record; lead investors include AI Fund, o2h ventures, Canaccord Genuity Group, Eight Capital.

Investor typeCountShare
Venture capital58%
Private equity23%
Bank & private debt12%
Other / undisclosed5387%
Coming soon